Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.
about
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized micePriming of protective T cell responses against virus-induced tumors in mice with human immune system componentsMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allNew generation humanized mice for virus research: comparative aspects and future prospectsInadequate clearance of translocated bacterial products in HIV-infected humanized miceCell delivery of therapeutic nanoparticlesValidation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretroviralsA growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse casesA topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu miceHumanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesisA Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo ModelsProtection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection.Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse modelRNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT miceProduction of bone marrow, liver, thymus (BLT) humanized mice on the C57BL/6 Rag2(-/-)γc(-/-)CD47(-/-) backgroundOral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model.Humanized Rag1-/- γc-/- mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routesHuman hemato-lymphoid system mice: current use and future potential for medicine.Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- miceLinks between progressive HIV-1 infection of humanized mice and viral neuropathogenesisCD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice.Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.Dysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury. Protective role of peroxisome proliferator-activated receptor-γ.Expansion of activated memory CD4+ T cells affects infectivity of CCR5-tropic HIV-1 in humanized NOD/SCID/JAK3null mice.Loss of neuronal integrity during progressive HIV-1 infection of humanized mice.Mice with human immune system components as in vivo models for infections with human pathogens.Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized micePD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads.The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment.Hypogammaglobulinemia in BLT humanized mice--an animal model of primary antibody deficiency.Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory DiseasesFatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infectionRodent models for HIV-associated neurocognitive disorders.Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized miceMultiple restrictions of human immunodeficiency virus type 1 in feline cells.Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.
P2860
Q24603574-B6BD5091-4BFE-4E1C-8640-097A7E32DF24Q24645297-276D3DF8-01FA-45DC-9380-88938B7BC25AQ26823568-2F505141-8C0A-4B9A-ADFB-B783F3CA9CB0Q27014786-8FB8E08E-A51B-4223-8970-CD3EC0D5821FQ27314977-853A4D26-635C-4D31-ACC6-4E409362066AQ28385606-FBF644DA-C4DC-410B-AFBD-60592DE047D4Q28469262-7789356D-C894-4ADC-8DF1-5A071314B255Q28477511-E291CEB3-535E-4682-8D85-0047A2169C38Q28478394-74C3CC33-96D5-4B76-ACC7-83DDC7598EB0Q28728527-53BED898-ECAA-4C47-A1DF-1C1012CC12FFQ28756080-B1B0FEC3-EBB1-4D20-A0A8-9FA677D0DD07Q30379545-F04F14C4-AFD8-4F5D-A85A-D7CFE808DB5FQ33514823-C996072B-D2B0-4ECB-8BD9-26905F3F453CQ33625213-FFDE410C-C5E0-4ADA-9AFE-56E58BFF425DQ33676640-048673FB-E7EE-4653-AB57-A2D0B7C8274DQ33730699-C2B55E63-529D-43FF-A8A7-2828A05CE093Q33766637-3BEA579F-539B-45BB-B046-1D908884DAF8Q33784852-E502CCEE-8855-4B4E-8E4F-64A74F986567Q33939330-1F98A7C7-D013-4B4D-84A2-62FCF36D5A6DQ33995307-753FAE34-AAFA-4887-9539-C114E252C306Q34100221-BA277DFB-A465-4691-9062-FB29D1B5B8DAQ34358241-8CA207DC-0FA9-473B-B925-EDA1386002E8Q34433569-61341531-1A84-40F6-9DC8-F9640372DCAFQ34474320-E723E36F-F955-4867-A8FC-856352CF4ADBQ34480264-D8D60315-F2C7-4776-9C15-6B16BDE92482Q34542521-14C99A5A-60FD-4048-9183-30545384861FQ34690832-6148F610-C216-4F57-8B17-9D92EAE3807FQ34920166-163597A8-E191-4318-BCAA-ABFB06D27932Q34975218-86023D00-0A11-4AD7-B25F-31491740EB46Q34979163-673A59F5-344B-4B30-8424-C3CF9285E4E4Q35035610-29A36F87-1E9F-4875-8A4F-1ED271CA2314Q35206268-B21A4CA3-1198-47E9-93C5-72D37A3648B1Q35291397-5352EA9D-2038-4D47-B724-C33AA0D52859Q35738486-F49DC2C6-6F6E-4BB2-B3EA-618F4801B3CEQ35757391-F845C935-C49F-408D-9133-A9D326A34AF7Q35783479-1917B099-E648-41DE-BC8A-238B69DE3B35Q35803957-2390506C-2F93-4E85-BE78-BD15CFD241C2Q35822619-B913A609-175E-4358-B55C-3F75D6A41BD6Q35914370-A16BA16A-C583-4646-B563-675E7A759E71Q35957271-564807BB-4DC5-4BC0-90C7-AD8AE6D8172D
P2860
Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Human immunodeficiency virus t ...... BALB/c-Rag2-/-gammac-/- mice.
@ast
Human immunodeficiency virus t ...... BALB/c-Rag2-/-gammac-/- mice.
@en
type
label
Human immunodeficiency virus t ...... BALB/c-Rag2-/-gammac-/- mice.
@ast
Human immunodeficiency virus t ...... BALB/c-Rag2-/-gammac-/- mice.
@en
prefLabel
Human immunodeficiency virus t ...... BALB/c-Rag2-/-gammac-/- mice.
@ast
Human immunodeficiency virus t ...... BALB/c-Rag2-/-gammac-/- mice.
@en
P2093
P2860
P356
P1433
P1476
Human immunodeficiency virus t ...... d BALB/c-Rag2-/-gammac-/- mice
@en
P2093
Charles Wood
Hannah Sneller
Howard E Gendelman
John G Sharp
John T West
Lisa Walters
Samuel J Pirruccello
Santhi Gorantla
P2860
P304
P356
10.1128/JVI.02010-06
P407
P577
2006-12-20T00:00:00Z